μ-crystallin, a NADPH-dependent T3-binding protein in cytosol

Trends in Endocrinology and Metabolism

Volumn 18, Issue 7, 2007, Pages 286-289

  Suzuki, Satoru ^a   Mori, Jun ichirou ^a   Hashizume, Kiyoshi ^a  

^a SHINSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; LIOTHYRONINE; MU CRYSTALLIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; THYROID HORMONE; THYROID HORMONE RECEPTOR; UNCLASSIFIED DRUG;

BINDING AFFINITY; BINDING SITE; CELL TYPE; CYTOSOL; CYTOSOLIC FRACTION; HEARING IMPAIRMENT; HORMONE ACTION; HORMONE BINDING; HUMAN; MUTATION; NONHUMAN; ORTHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; THYROID FUNCTION; THYROID GLAND;

ANIMALS; CRYSTALLINS; CYTOSOL; HUMANS; MODELS, BIOLOGICAL; NADP; PROTEIN BINDING; TRIIODOTHYRONINE;

EID: 34548247215     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tem.2007.07.002     Document Type: Review

References (37)

1. Friesema E.C., et al. Thyroid hormone transporters. Vitam. Horm. 70 (2005) 137-167
2. Primm T.P., and Gilbert H.F. Hormone binding by protein disulfide isomerase, a high capacity hormone reservoir of the endoplasmic reticulum. J. Biol. Chem. 276 (2001) 281-286
3. Casas F., et al. A variant form of the nuclear triiodothyronine receptor c-ErbAalpha1 plays a direct role in regulation of mitochondrial RNA synthesis. Mol. Cell. Biol. 19 (1999) 7913-7924
4. Obata T., et al. Thyroid hormone down-regulates p55, a thyroid hormone-binding protein that is homologous to protein disulfide isomerase and the beta-subunit of prolyl-4-hydroxylase. J. Biol. Chem. 263 (1988) 782-785
5. Tata J.R. A cellular thyroxine-binding protein fraction. Biochim. Biophys. Acta 28 (1958) 91-94
6. Hamada S., et al. Specific binding proteins of thyroxine and triiodothyronine in liver soluble proteins. Biochim. Biophys. Acta 201 (1970) 479-492
7. 3 binding. Endocrinology 119 (1986) 710-719
8. Kobayashi M., et al. A novel NADPH-dependent cytosolic 3,5,3′-triiodo-L-thyronine-binding protein (CTBP; 5. 1S) in rat liver: a comparison with 4. 7S NADPH-dependent CTBP. Endocrinology 129 (1991) 1701-1708
9. Vié M.P., et al. Purification, molecular cloning, and functional expression of the human nicodinamide-adenine dinucleotide phosphate-regulated thyroid hormone-binding protein. Mol. Endocrinol. 11 (1997) 1728-1736
10. Kim R.Y., et al. μ-crystallin is a mammalian homologue of Agrobacterium ornithine cyclodeaminase and is expressed in human retina. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 9292-9296
11. Wistow G. Lens crystallins: gene recruitment and evolutionary dynamism. Trends Biochem. Sci. 18 (1993) 301-306
12. 3-mediated transactivation. Endocrinology 143 (2002) 1538-1544
13. 3 holder in vivo. Mol. Endocrinol. 21 (2007) 885-894
14. 3)-binding protein (p38CTBP) molecule: analyses with deletion mutants. Horm. Metab. Res. 35 (2003) 577-582
15. Oshima A., et al. CRYM mutations cause deafness through thyroid hormone binding properties in the fibrocytes of the cochlea. J. Med. Genet. 43 (2006) e25
16. Cheng Z., et al. Crystal structure of human μ-crystallin complexed with NADPH. Protein Sci. 16 (2007) 329-335
17. Abe S., et al. Identification of CRYM as a candidate responsible for nonsyndromic deafness, through cDNA microarray analysis of human cochlear and vestibular tissues. Am. J. Hum. Genet. 72 (2003) 73-82
18. Suzuki S., et al. Ontogenesis of the high affinity NADPH-dependent cytosolic 3,5,3′-triiodo-L-thyronine-binding protein in rat. Endocrinology 129 (1991) 2571-2574
19. Suzuki S., et al. Cell-specific expression of NADPH-dependent cytosolic 3,5,3′-triiodo-L-thyronine-binding protein (p38CTBP). Eur. J. Endocrinol. 148 (2003) 259-268
20. de Chaldéem M., et al. Quantitative assessment of transcriptome differences between brain territories. Genome Res. 13 (2003) 1646-1653
21. Segovia L., et al. Two roles for μ-crystallin: a lens structural protein in diurnal marsupials and a possible enzyme in mammalian retinas. Mol. Vis. 3 (1997) 9
22. Umeda S., et al. Molecular composition of drusen and possible involvement of anti-retinal autoimmunity in two different forms of macular degeneration in cynomolgus monkey (Macaca fascicularis). FASEB J. 19 (2005) 1683-1685
23. Roberts M.R., et al. Making the gradient: thyroid hormone regulates cone opsin expression in the developing mouse retina. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 6218-6223
24. 3 in primary cultured rat hepatocytes. Endocr. J. 40 (1993) 399-404
25. Hashizume K., et al. Effect of active vitamin D3 on the levels of NADPH-dependent cytosolic 3,5,3′-triiodo-L-thyronine-binding protein. Biochem. Biophys. Res. Commun. 177 (1991) 388-394
26. Takeda T., et al. Response of hepatic proteins to 3,5,3′-triiodo-L-thyronine in diabetic rats. J. Endocrinol. 143 (1994) 55-63
27. 3 binding. J. Endocrinol. 123 (1989) 99-104
28. Dieudonné S.C., et al. Differential display of human marrow stromal cells reveals unique mRNA expression patterns in response to dexamethasone. J. Cell. Biochem. 76 (1999) 231-243
29. Yang J., et al. Decreased SLIM1 expression and increased gelsolin expression in failing human hearts measured by high-density oligonucleotide arrays. Circulation 102 (2000) 3046-3052
30. Middleton F.A., et al. Gene expression profiling alterations of specific metabolic pathways in schizophrenia. J. Neurosci. 22 (2002) 2718-2729
31. Mousses S., et al. Clinical validation of candidate genes associated with prostate cancer progression in the CWR22 model system using tissue microarrays. Cancer Res. 62 (2002) 1256-1260
32. Chong I.-W., et al. Great potential of a panel of multiple hMTH1, SPD, ITGA11, and COL11A1 markers for diagnosis of patients with non-small lung cancer. Oncol. Rep. 16 (2006) 981-988
33. Khalil A.A., and James P. Biomarker discovery: a proteomic approach for brain cancer profiling. Cancer Sci. 98 (2007) 201-213
34. Aoki N., et al. μ-crystallin, thyroid hormone-binding protein, is expressed abundantly in the murine inner root sheath cells. J. Invest. Dermatol. 115 (2000) 402-405
35. Hennebold J.D. Characterization of the ovarian transcriptome through the use of differential analysis of gene expression methodologies. Hum. Reprod. Update 10 (2004) 227-239
36. Ko C., et al. Follicle-stimulating hormone suppresses cytosolic 3,5,3′-triiodothyronine-binding protein messenger ribonucleic acid expression in rat granulosa cells. Endocrinology 144 (2003) 2360-2367
37. Reed P.W., et al. Abnormal expression of μ-crystallin in facioscapulohumeral muscular dystrophy. Exp. Neurol. 205 (2007) 583-586